Evidence map›Paper›PMID 40205764›Full record

ArticlePharmaceutical biology2025

Seung-Ju Hwang, Chang-Seob Seo, Dong-Cheol Baek, Tae-Wook Woo, Jing-Hua Wang, Jin-Seok Lee, Yu-Jin Choi, Ji-Yeon Gu, Dong-Seon Kim, Chang-Gue Son

Abstract read
In one paragraph

Article in Pharmaceutical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Seung-Ju HwangInstitute of Bioscience & Integrative Medicine, Daejeon University, Daejeon, Republic of Korea.ORCID 0000-0003-1037-9133
Chang-Seob SeoKM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.ORCID 0000-0002-8156-446X
Dong-Cheol BaekInstitute of Bioscience & Integrative Medicine, Daejeon University, Daejeon, Republic of Korea.ORCID 0000-0003-4523-8920
Tae-Wook WooInstitute of Bioscience & Integrative Medicine, Daejeon University, Daejeon, Republic of Korea.ORCID 0009-0001-1311-829X
Jing-Hua WangInstitute of Bioscience & Integrative Medicine, Daejeon University, Daejeon, Republic of Korea.ORCID 0000-0002-2034-7429
Jin-Seok LeeInstitute of Bioscience & Integrative Medicine, Daejeon University, Daejeon, Republic of Korea.ORCID 0000-0002-1046-2132
Yu-Jin ChoiInstitute of Bioscience & Integrative Medicine, Daejeon University, Daejeon, Republic of Korea.ORCID 0000-0003-4371-6239
Ji-Yeon GuInstitute of Bioscience & Integrative Medicine, Daejeon University, Daejeon, Republic of Korea.ORCID 0009-0007-6623-1169
Dong-Seon KimKM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.ORCID 0000-0002-1711-0906
Chang-Gue SonInstitute of Bioscience & Integrative Medicine, Daejeon University, Daejeon, Republic of Korea.ORCID 0000-0003-4876-0167

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextWDJ-S4, a standardized herbal formula, has been prescribed for refractory functional dyspepsia (FD) in Korea, but the detailed mechanisms are lacking.

objectiveThe present study investigates the acceleration of gastrointestinal (GI) motility by WDJ-S4 and its potential mechanisms. MATERIALS AND

methodsFor five days, WDJ-S4 (50, 100 and 200 mg/kg) or mosapride (3 mg/kg) was orally given to BALB/c mice. After 20 h of fasting, loperamide (10 mg/kg, i.p.) was given to the mice except for normal group. To assess gastric emptying or intestinal propulsion, 500 μL of 0.05% phenol red or 200 μL of 5% charcoal diet was given once orally.

resultsLoperamide delayed gastric emptying and intestinal propulsion, while WDJ-S4 ameliorated peristaltic dysfunction, evidenced by reductions of remaining phenol red in the stomach and a marked increase of charcoal propulsion in the intestine. WDJ-S4 also normalized levels of acetylcholine and acetylcholine-related enzymes, including choline acetyltransferase (ChAT) and acetylcholinesterase (AChE), in the gastric antrum and jejunum. C-kit level and smooth muscle contraction-related genes were elevated by WDJ-S4 in both the gastric antrum and jejunum.

conclusionOverall, WDJ-S4 can effectively promote GI motility. The efficacy is associated with modulation of acetylcholine pathway and the interstitial cells of Cajal (ICCs) activation. All the results provide scientific evidence supporting the clinical usage of WDJ-S4 for FD.

Indexed as

AcetylcholineDyspepsiaGastrointestinal MotilityLoperamideAnimalsDisease Models, AnimalDose-Response Relationship, DrugGastric EmptyingGastrointestinal AgentsMaleMiceMice, Inbred BALB CAcetylcholineGastrointestinal AgentsLoperamidegastrointestinal tractherbal medicineInterstitial cells of Cajalperistalsis

Identifiers

PMID40205764
PMCPMC11986872

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.